RC: 640303
NOTORE CHEMICAL INDUSTRIES PLC UNAUDITED INTERIM FINANCIAL STATEMENTS
FOR THE FIFTEEN MONTHS PERIOD ENDED 31 DECEMBER 2021
NOTORE CHEMICAL INDUSTRIES PLC
UNUADITED INTERIM FINANCIAL STATEMENTS
FOR THE FIFTEEN MONTHS PERIOD ENDED 31 DECEMBER 2021
Page | ||
Financial statements | ||
Consolidated statements of profit or loss and other comprehensive income for Q5 2021 | 1 | |
Consolidated statements of profit or loss and other comprehensive income for fifteen months ended 31 December 2021 | 2 | |
Consolidated statements of financial position | 3 | |
Statements of changes in equity | 4 | |
Statements of cash flows | 6 | |
Note | Notes to the financial statements | |
1.0 | General information | 7 |
2.0 | Basis of preparation and adoption of IFRSs | 7 |
3.0 | Changes in accounting policy and disclosures | 7 |
4.0 | Summary of significant accounting policies | 8 |
4.1 | Foreign currency translation | 8 |
4.2 | Trade receivables | 8 |
4.3 | Revenue recognition | 8 |
4.4 | Cash and cash equivalents | 9 |
4.5 | Inventories | 9 |
4.6 | Non-current assets held for sale | 9 |
4.7 | Trade payables | 9 |
4.8 | Provisions and contingent liabilities | 9 |
4.9 | Property, plant and equipment | 9 |
4.10 | Intangible assets | 10 |
4.11 | Impairment of non-financial assets | 10 |
4.12 | Financial instruments | 11 |
4.13 | Offsetting financial instruments | 12 |
4.14 | Impairment of financial assets | 12 |
4.15 | Share capital | 12 |
4.16 | Income taxation | 12 |
4.17 | Employee benefits | 13 |
4.18 | Leases | 13 |
4.19 | Government grants | 14 |
4.20 | Cost of sales | 14 |
4.21 | Borrowings | 14 |
4.22 | Borrowings costs | 14 |
4.23 | Investment property | 14 |
4.24 | Consolidation | 14 |
4.25 | Segment reporting | 15 |
4.26 | Export expansion grant and Negotiable duty credit certificates | 15 |
4.27 | Related parties | 15 |
5 | Critical accounting estimates and judgements | 15 |
6 | Financial risk management | 17 |
7 | Revenue from contracts with customers | 18 |
8 | Cost of sales | 18 |
9a | Administrative expenses | 18 |
9b | Selling and distribution expenses | 19 |
10 | Other income | 19 |
11 | Finance income and costs | 19 |
12 | Income tax expense | 20 |
13 | Earnings per share (EPS) | 21 |
14 | Property, plant and equipment | 22 |
15 | Right of use assets | 23 |
16 | Investment property | 23 |
17 | Intangible assets | 23 |
18 | Inventories | 23 |
19 | Trade and other receivables | 24 |
20 | Cash and cash equivalents | 24 |
21 | Share capital | 24 |
22 | Retained earnings | 24 |
23 | Employee benefit obligations | 25 |
24 | Borrowings | 26 |
25 | Trade and other payables | 27 |
26 | Related party transactions | 27 |
27 | Investments in subsidiaries | 28 |
28 | Revenue from contracts with customers(Three months) | 29 |
29 | Cost of sales(Three months) | 29 |
30a | Administrative expenses(Three months) | 29 |
30b | Selling and distribution expenses(Three months) | 30 |
31 | Other income(Three months) | 30 |
32 | Finance income and costs(Three months) | 30 |
33 | Securities Trading Policy | 30 |
NOTORE CHEMICAL INDUSTRIES PLC
UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE THREE MONTHS PERIOD ENDED 31 DECEMBER 2021
(All amounts are in thousands of Naira, unless otherwise stated) | |||||
Group | Company | ||||
Three months | Three months | Three months | Three months | ||
Note | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2021 | 31 Dec 2020 | |
N'000 | N'000 | N'000 | N'000 | ||
Revenue from contracts with customers | 28 | 9,558,684 | 3,569,894 | 9,205,115 | 3,308,224 |
Cost of sales | 29 | (6,655,957) | (4,962,585) | (6,655,957) | (4,854,546) |
Gross profit | 2,902,727 | (1,392,691) | 2,549,158 | (1,546,322) | |
Administrative expenses | 30a | (1,211,215) | (1,425,342) | (1,137,091) | (1,358,798) |
Selling and distribution expenses | 30b | (53,254) | (26,140) | (52,415) | (26,140) |
Other income | 31 | 10,372,105 | 363,386 | 10,490,350 | 363,366 |
Operating income | 12,010,362 | (2,480,788) | 11,850,002 | (2,567,894) | |
Finance income | 32 | - | 96 | - | 96 |
Finance cost | 32b | (12,072,042) | (4,083,890) | (12,072,042) | (4,083,890) |
Exceptional Item | 32b | - | - | ||
Finance costs - (net) | 32 | (12,072,041) | (4,083,793) | (12,072,041) | (4,083,793) |
Loss before income tax | (61,679) | (6,564,581) | (222,040) | (6,651,688) | |
Income tax | - | - | - | - | |
Profit/(loss) for the period | (61,679) | (6,564,581) | (222,040) | (6,651,688) | |
Other comprehensive income: | |||||
Items that will not be reclassified to profit or loss | |||||
Total items that will not be reclassified to profit or loss | - | - | - | - | |
Items that may be subsequently reclassified to profit or loss | |||||
Currency translation difference | (44,672) | 370 | - | - | |
Total items that may be reclassified to profit or loss | (44,672) | 370 | - | - | |
Other comprehensive income / (loss) for the period- | |||||
net of tax | (44,672) | 370 | - | - | |
Total comprehensive profit / (loss) for the period | (106,352) | (6,564,211) | (222,040) | (6,651,688) | |
Total comprehensive profit /(loss) for the year attributable to: | |||||
Equity holders of the parent company | (106,352) | (6,564,211) | (222,040) | (6,651,688) | |
Non controlling interest | - | - | - | - | |
Earnings per share for loss attributable to the equity | |||||
holders of the company | |||||
Basic EPS (Naira) | (0.04) | (4.07) | (0.14) | (4.13) | |
1
NOTORE CHEMICAL INDUSTRIES PLC
UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE FIFTEEN MONTHS PERIOD ENDED 31 DECEMBER 2021
(All amounts are in thousands of Naira, unless otherwise stated) | ||||||
Group | Company | |||||
Fifteen months | Twelve months | Fifteen months | Twelve months | |||
Note | 31 Dec 2021 | 30 Sept 2020 | 31 Dec 2021 | 30 Sept 2020 | ||
N'000 | N'000 | N'000 | N'000 | |||
Revenue from contracts with customers | 7 | 27,025,385 | 18,799,043 | 25,484,426 | 18,799,043 | |
Cost of sales | 8 | (28,696,351) | (21,678,653) | (27,991,343) | (21,678,653) | |
Gross profit | (1,670,966) | (2,879,610) | (2,506,917) | (2,879,610) | ||
Administrative expenses | 9a | (6,955,713) | (6,016,297) | (6,537,019) | (5,997,731) | |
Selling and distribution expenses | 9b | (272,047) | (293,696) | (266,707) | (293,696) | |
Other income | 10 | 17,266,551 | 18,675,245 | 17,939,101 | 18,675,245 | |
Operating income | 8,367,825 | 9,485,642 | 8,628,458 | 9,504,208 | ||
Finance income | 11a | 388 | 1,074 | 388 | 1,074 | |
Finance cost | 11b | (28,770,914) | (23,409,290) | (28,770,914) | (23,409,290) | |
Finance costs - (net) | 11 | (28,770,526) | (23,408,216) | (28,770,526) | (23,408,216) | |
Loss before income tax | (20,402,701) | (13,922,574) | (20,142,068) | (13,904,008) | ||
Income tax | - | 7,525,938 | - | 7,525,938 | ||
Profit/(loss) for the period | (20,402,701) | (6,396,636) | (20,142,068) | (6,378,070) | ||
Other comprehensive income: | ||||||
Items that will not be reclassified to profit or loss | ||||||
Remeasurement of employee benefit obligations | - | (371,864) | - | (371,864) | ||
Deferred tax credit/(charge) on actuarial loss/gain | - | 111,559 | - | 111,559 | ||
Revaluation surplus on property, plant and equipment | - | 233,472 | - | 233,472 | ||
Deferred tax charge on revaluation surplus | - | (70,042) | - | (70,042) | ||
Total items that will not be reclassified to profit or loss | - | (96,875) | - | (96,875) | ||
Items that may be subsequently reclassified to profit or loss | ||||||
Currency translation difference | - | 27,621 | - | - | ||
Total items that may be reclassified to profit or loss | - | 27,621 | - | - | ||
Other comprehensive income / (loss) for the period- | ||||||
net of tax | - | (69,254) | - | (96,875) | ||
Total comprehensive profit / (loss) for the period | (20,402,701) | (6,465,890) | (20,142,068) | (6,474,945) | ||
Total comprehensive profit /(loss) for the year attributable to: | ||||||
Equity holders of the parent company | (20,402,701) | (6,465,890) | (20,142,068) | (6,474,945) | ||
Non controlling interest | - | - | - | - | ||
Earnings per share for loss attributable to the equity | ||||||
holders of the company | ||||||
Basic EPS (Naira) | 13 | (12.66) | (3.97) | (12.49) | (3.96) | |
The notes on pages 7 to 30 are an integral part of these financial statements.
2
NOTORE CHEMICAL INDUSTRIES PLC
UNAUDITED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
AS AT 31 DECEMBER 2021
(All amounts are in thousands of Naira, unless otherwise stated) | |||||
Group | Company | ||||
30 Sept 2020 | 30 Sept 2020 | ||||
Note | 31 Dec 2021 | Restated | 31 Dec 2021 | Restated | |
N'000 | N'000 | N'000 | N'000 | ||
Non-current assets | |||||
Property, plant and equipment | 14 | 148,640,207 | 145,278,255 | 148,640,207 | 145,278,254 |
Right of use assets | 15(a) | 30,429 | 152,647 | 30,429 | 152,647 |
Investment property | 16 | 68,333,559 | 53,174,118 | 68,333,559 | 53,174,118 |
Intangible asset | 17 | - | 12,509 | - | 12,509 |
Investments in subsidiaries | 27 | - | - | 50,255 | 50,255 |
Total non-current assets | 217,004,195 | 198,617,529 | 217,054,450 | 198,667,783 | |
Current assets | |||||
Inventories | 18 | 9,978,056 | 5,950,222 | 9,937,080 | 5,950,222 |
Trade and other receivables | 19 | 4,631,971 | 11,315,718 | 4,917,085 | 11,315,718 |
Pledged assets | 19 | 4,540,129 | 4,540,129 | 4,540,129 | 4,540,129 |
Cash at bank and in hand | 20 | 1,164,890 | 337,347 | 1,029,885 | 336,207 |
Total current assets | 20,315,046 | 22,143,416 | 20,424,179 | 22,142,276 | |
Total assets | 237,319,241 | 220,760,945 | 237,478,629 | 220,810,059 | |
Equity | |||||
Ordinary shares | 21 | 806,033 | 806,033 | 806,033 | 806,033 |
Share premium | 27,995,916 | 27,995,916 | 27,995,916 | 27,995,916 | |
Asset revaluation reserves | 60,531,534 | 63,961,570 | 60,531,534 | 63,961,570 | |
Foreign currency translation reserve | - | 544,995 | - | - | |
Retained earnings | 22 | (46,217,611) | (29,164,393) | (45,967,914) | (29,255,882) |
Treasury shares reserve | (1,080,831) | (1,080,831) | (1,080,831) | (1,080,831) | |
Total equity | 42,035,041 | 63,063,290 | 42,284,738 | 62,426,806 | |
Liabilities | |||||
Non-current liabilities | |||||
Borrowings | 24a | 79,962,615 | 89,669,185 | 79,962,615 | 89,669,185 |
Employee benefit obligation | 23 | 1,895,681 | 1,620,322 | 1,895,681 | 1,620,322 |
Grant liability | 24b | 2,596,828 | 4,026,113 | 2,596,828 | 4,026,113 |
Deferred tax liability | 12b | 10,247,000 | 10,247,000 | 10,247,000 | 10,247,000 |
Total non-current liabilities | 94,702,124 | 105,562,620 | 94,702,124 | 105,562,620 | |
Current liabilities | |||||
Borrowings | 24a | 49,102,306 | 18,681,317 | 49,102,306 | 18,681,317 |
Lease liability | 15(b) | - | 135,120 | - | 135,120 |
Trade and other payables | 25 | 50,312,526 | 32,076,683 | 50,222,220 | 32,762,281 |
Grant liability | 24b | 1,167,241 | 1,202,959 | 1,167,241 | 1,202,959 |
Current tax liabilities | 12 | (1) | 38,956 | (1) | 38,956 |
Total current liabilities | 100,582,072 | 52,135,035 | 100,491,766 | 52,820,633 | |
Total liabilities | 195,284,196 | 157,697,655 | 195,193,890 | 158,383,253 | |
Total equity and liabilities | 237,319,241 | 220,760,945 | 237,478,629 | 220,810,059 | |
The financial statements on pages 1 to 30 were approved and authorised for issue by the board of directors on 28 January 2022 and signed on its behalf by:
Mr. Ohis Ohiwerei | Mr. Onajite P. Okoloko | Mr. Bolarin Tolujo | ||
Managing Director/CEO | Director | Chief Financial Officer | ||
FRC/2017/CIBN/00000016412 | FRC/2014/NIM/00000007662 | FRC/2018/ICAN/00000018981 |
The notes on pages 7 to 30 are an integral part of these financial statements.
3
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Notore Chemical Industries plc published this content on 28 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 January 2022 18:52:00 UTC.